Cobactan LC, 75 mg, Intramammary Ointment for Lactating Cattle

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: VMD (Veterinary Medicines Directorate)

Ingredjent attiv:

Cefquinome

Disponibbli minn:

MSD Animal Health UK Limited

Kodiċi ATC:

QJ51DE90

INN (Isem Internazzjonali):

Cefquinome

Għamla farmaċewtika:

Intramammary ointment

Tip ta 'preskrizzjoni:

POM-V - Prescription Only Medicine – Veterinarian

Grupp terapewtiku:

Cattle

Żona terapewtika:

Antimicrobial

L-istatus ta 'awtorizzazzjoni:

Expired

Data ta 'l-awtorizzazzjoni:

1996-03-27

Karatteristiċi tal-prodott

Revised: July 2019
AN: 02185/2017
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cobactan LC, 75mg, intramammary ointment for lactating cattle
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each prefilled syringe of 8g contains:
ACTIVE SUBSTANCE:
Cefquinome 75 mg (as cefquinome sulphate)
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
White to slightly yellow, oily viscous homogeneous intramammary
ointment.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Lactating cows.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of clinical mastitis in the lactating dairy cow
caused by the following
cefquinome-sensitive organisms : _Streptococcus uberis, Streptococcus
dysgalactiae, _
_Staphylococcus aureus_ and_ Escherichia coli_.
4.3
CONTRAINDICATIONS
Not
to
be
administered
to
animals
which
are
known
to
be
hypersensitive
to
cephalosporin antibiotics and other ß-lactam antibiotics.
Do not use the cleaning towel if lesions are present on the teat.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Use of the product should be based on susceptibility testing and take
into account
official and local antimicrobial policies. Inappropriate use of the
product may increase
the
prevalence
of
bacteria
resistant
to
cefquinome
and
may
decrease
the
effectiveness
of
treatment
with
cephalosporins,
due
to
the
potential
for
cross-
resistance.
Revised: July 2019
AN: 02185/2017
Page 2 of 5
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals
Penicillins
and
cephalosporins
may
cause
hypersensitivity
(allergy)
following
injection, inhalation, ingestion or skin contact. Hypersensitivity to
penicillins may lead
to cross sensitivity to cephalosporin and vice versa. Allergic
reactions to these
substances may occasionally be serious.
1.
Handle this product with great care to avoid exposure, taking all
recommended
precautions.
2.
Do n